APPLIED CLINICAL TRIALS Issue Alert Having trouble viewing this email? Click here
Web Version | View Digital Edition | Subscribe
In our November issue:

FEATURED

 Malaysia's Early Stage Push
AJA Ooi, KF Khalid
With over 20 years of experience in conducting late-phase clinical trials, this report explores the untapped potential of early stage research in Malaysia and the initiatives undertaken to build up the nation's clinical trials ecosystem.

Precision Oncology: Breaking Down Barriers
Emile Youssef, MD, PhD
While great strides have been made in the field of precision oncology (e.g., immunotherapy, cell therapy), widespread use of these treatments remains elusive. There are three critical challenges that need to be addressed to make personalized cancer care a reality.

ICH E6 (R2) Update in Practice
Patrick Hughes
A roundtable of industry experts gather to discuss the implementation of updated ICH E6 (R2) requirements and the shift toward applying risk-based study execution approaches across end-to-end development processes.


NEWS
Washington Report: Jill Wechsler on the challenge for sponsors in balancing trial disclosure and patient privacy requirements.

EU Report: Peter O’Donnell explores the potential disruptions from strategy shifts in European health policy.

Q&A: How one company is using its laboratory data to be an effective partner to biopharma drug developers.

CLOSING THOUGHT
China Enters New Era of R&D
Albert Tsai
As China’s pharma industry continues to evolve and mature, it is hoped that overseas expansion and greater innovation will be exported to serve the interests of patients.
View the digital Issue
image
 
BLOGS
Dementia Doesn’t Discriminate-Neither Should Dementia Research
The Secrets to Survival in the Emerging Biopharma Industry
Who Has the Right to See Clinical Trial Data?
WEBCAST
Transforming Regulatory Affairs: Sharing Industry Peer Perspectives
Listen to case studies to hear how companies are transforming their regulatory affairs and realizing the benefits of integrating their safety, regulatory, and quality approaches for more efficient and predictable solutions.

If you would like to submit an article to Applied Clinical Trials, contact Lisa Henderson, Editorial Director - lhenderson@mmhgroup.com

Applied Clinical Trials is free to qualified subscribers. To subscribe, click here.

Click here to contact the Applied Clinical Trials sales team.
Twitter LinkedIn